Prediction of the presence of ovarian cancer at surgery by an immunochemical panel: CA125 and copper-to-zinc ratio
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 35 (2) , 246-250
- https://doi.org/10.1016/0090-8258(89)90053-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic testGynecologic Oncology, 1987
- Serum copper level in gynecologic malignanciesAmerican Journal of Obstetrics and Gynecology, 1987
- Evaluation of serum CA 125 levels in the monitoring of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1987
- A review of second-look laparotomy for ovarian cancerGynecologic Oncology, 1986
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Clinical, Biochemical, and Pharmacological Role of ZincAnnual Review of Pharmacology and Toxicology, 1979
- Ovarian tumor antigensCancer, 1978
- Analysis of human ovarian tumor antigens using heterologous antisera: Detection of new antigenic systemsInternational Journal of Cancer, 1978
- The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963–1973Cancer, 1976
- Tissue Zinc in Malignant DiseaseNature, 1973